FAQ Is it safe to take glutathione for skin lightening while breastfeeding
However, chitosans pH solubility profile limits its application in the small intestine, and its marine origin, batch variability, and limited GMP-grade availability restrict translational development (Li et al., 2025)
Roche is advancing an oral GLP-1 receptor agonist, CT-996, which it gained through its 2024 acquisition of Carmot Therapeutics, a Berkeley, California-based bio/pharmaceutical company, in a deal worth up to $3.1 billion ($2.7 billion at closing plus $400 million in potential milestone payments)
The timeline for expected therapeutic response may vary based on the condition being treated and individual patient factors
These are meaningful metabolic benefits- not pharmaceutical equivalents